V503

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for V503, covering 2014-12-22 to 2026-06-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) [Phase 3]